Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients

NCT03125850 | Completed

• 1 other identifier: Zhongshan OC
• Study Type: interventional
• Target: 240
• Locations: 1 country
• Sites: 1

Brief Summary

This study will compare the glaucoma day-ward patients' efficacy with inpatients by evaluating the glaucoma knowledge and psychology , and will analysis the reasons of the differences. Half of participants will receive treatment in day-ward, while the other half will receive treatment in hospital.

Conditions

Glaucoma

Keywords

knowledge; psychology

Outcome Measures

Primary Outcomes (2)

• Change of depression and anxiety score

  The outcome will be measured by The Hospital Depression and Anxiety Scale (HADS). It consists of two subscales: HDAS-anxiety and HADS-depression. Each item is srored from 0-3, with higher scores indicating a higher level of depression and anxiety. For each of the seven-item subscales, the minimum sum score is 0, and the maximum is 21.

  at baseline and 1 hour before discharge

• Change of glaucoma knowledge score

  The outcome will be measured by The Gray Glaucoma Knowledge Questionaire. This quesionanire has a total maximum score of 17, with higher scores representing better knowledge.

  at baseline and 1 hour before discharge

Study Arms (2)

day-ward group

EXPERIMENTAL

Other: randomized to day ward

inpatient group

ACTIVE COMPARATOR

Other: randomized to inpaitent

Interventions

randomized to day ward OTHER

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

day-ward group

randomized to inpaitent OTHER

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

inpatient group

Eligibility Criteria

• Age: 12 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient is diagnosed with glaucoma;
• Will receive glaucoma surgery;
• Voluntary participation in this study;
• Have enough language comprehension ability;
• Best corrected visual acuity reach 0.1 or better;
• Patient or his legal representative has sign the informed consent.

You may not qualify if:

• Patient with mental disorder;
• There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases;
• Patient with monocular blindness;
• Axial length≤20 mm;
• With other serious eye diseases;
• Neurologic diseases that could affect the visual field;
• months prior to research to participate in any clinical study;
• Researchers think not suitable to participate in this clinical trial subjects;
• Refused to sign the informed consent.

Sponsors & Collaborators

• Zhongshan Ophthalmic Center, Sun Yat-sen University: lead

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-San Univerdity

Guangzhou, Guangdong, China

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular Hypertension; Eye Diseases

Study Officials

• Mingkai Lin, MD

  Zhongshan Ophthalmic Center, Sun Yat-San University

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: chief physician

Study Record Dates

• First Submitted: April 16, 2017
• First Posted: April 24, 2017
• Study Start: August 10, 2017
• Primary Completion: December 10, 2017
• Study Completion: January 10, 2018
• Last Updated: July 23, 2020

Record last verified: 2020-07

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)